Cardiac radiotherapy–induced epigenetic memory underlies electrophysiologic and metabolic reprogramming
Journal of Clinical Investigation · 2026
DOI: 10.1172/jci193087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2026. Verfasst von Samuel D Jordan und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Cardiovascular Division. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Epigenesis, Genetic, Tachycardia, Ventricular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Stereotactic arrhythmia radiotherapy (STAR) is emerging as a highly effective treatment for ventricular tachycardia (VT). Growing evidence indicates that STAR favorably reprograms the electrical substrate by speeding conduction and/or prolonging repolarization via modulation of ion channel expression, although the mechanisms by which single-fraction radiation mediates durable changes in gene expression are incompletely understood. Here, we identify dynamic changes in the cardiomyocyte epigenome and transcriptome after irradiation (IR) in vivo and in vitro, including durably increased expression and chromatin accessibility of Scn5a (encodes the α subunit of the sodium channel, Na V 1.5), demonstrating a role for epigenetic memory in conduction velocity (CV) increases observed after STAR. Transcriptomic and epigenetic sequencing further identified dynamic changes in gene expression and regulatory regions involved in cellular repolarization, calcium handling, and metabolism after IR. These changes were mirrored by dose-dependent and cell-autonomous changes in repolarization, calcium flux, and mitochondrial respiration, highlighting important cellular processes that may mediate the therapeutic effects of STAR. Overall, we found that cardiomyocytes exposed to a single fraction of high-dose IR exhibited epigenetic reprogramming that mediated broad and dynamic physiologic responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Cardiovascular Division.
- Center for Noninvasive Cardiac Radiotherapy.
- Department of Developmental Biology, and.
- Department of Radiation Oncology, Washington University, School of Medicine, St. Louis, Missouri, USA.
- Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
- Mayo Clinic Comprehensive Cancer Center, Rochester, Minnesota, USA.
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- National Institutes of Health
- Additional Ventures Cures Collaborative
- Sarnoff Cardiovascular Research Foundation
Zitieren
APA
Jordan, S. D., Fu, S., Fulkerson, A., Hu, D., Ng, S., Zhang, D. M., Manikandan, S., Szymanski, J., Hu, N., Xie, Y., Bedi, A., Tabor, J., Boggs-Bailey, L., Strong, L., Hicks, S., Aryan, L., Gabriel, N., Hugo, G. D., Weng, K. C., …, & Rentschler, S. L. (2026). Cardiac radiotherapy–induced epigenetic memory underlies electrophysiologic and metabolic reprogramming. Journal of Clinical Investigation. https://doi.org/10.1172/jci193087
Vancouver
Jordan SD, Fu S, Fulkerson A, Hu D, Ng S, Zhang DM, et al. Cardiac radiotherapy–induced epigenetic memory underlies electrophysiologic and metabolic reprogramming. Journal of Clinical Investigation. 2026. doi:10.1172/jci193087
BibTeX
@article{Jordan2026,
author = {Jordan, Samuel D and Fu, Shuhua and Fulkerson, Abigail and Hu, Donghua and Ng, Sherwin and Zhang, David M and Manikandan, Sneha and Szymanski, Jeffrey and Hu, Nan and Xie, Yuqian and Bedi, Anish and Tabor, James and Boggs-Bailey, Lauren and Strong, Lori and Hicks, Stephanie and Aryan, Lavanya and Gabriel, Nishanth and Hugo, Geoffrey D and Weng, Kuo-Chan and Huebsch, Nathaniel and Schwarz, Julie K and Zhang, Bo and Rentschler, Stacey L},
title = {Cardiac radiotherapy–induced epigenetic memory underlies electrophysiologic and metabolic reprogramming},
journal = {Journal of Clinical Investigation},
year = {2026},
doi = {10.1172/jci193087}
}
EUVIMED